Article Information
History
- March 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Anni Moore, BSc1,
- Sara Bandres-Ciga, PhD2,
- Cornelis Blauwendraat, PhD2,
- Monica Diez-Fairen, PhD3,* and
- on behalf of the International Parkinson’s Disease Genomics Consortium (IPDGC)
- 1Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
- 2Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
- 3Fundació Docència i Recerca MútuaTerrassa and Movement Disorders Unit, Department of Neurology, University Hospital MútuaTerrassa, Terrassa 08221, Barcelona, Spain
- ↵*Corresponding author:
Dr. Monica Diez-Fairen, email: mdiez{at}mutuaterrassa.es. University Hospital MútuaTerrassa, Sant Antoni 19, Terrassa 08221, Barcelona, Spain.
Posted March 12, 2021.
A genetic and transcriptomic assessment of the KTN1 gene in Parkinson’s disease risk
